NVO vs AAPL: Which Stock is Better?
Side-by-side comparison of Novo Nordisk A S and Apple Inc in 2026
Comparison Updated:
NVO
Novo Nordisk A S
$0.00
AAPL
Apple Inc
$259.48
Key Metrics Comparison
| Metric | NVO | AAPL | Winner |
|---|---|---|---|
| Market Cap | $0.00M | $3.85T | AAPL |
| P/E Ratio | N/A | 33.85 | NVO |
| EPS (TTM) | $N/A | $7.55 | AAPL |
| Revenue Growth | 0.0% | 6.4% | AAPL |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze NVO
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is NVO or AAPL a better investment?
Comparing NVO and AAPL: Novo Nordisk A S has a market cap of $0.00M while Apple Inc has $3.85T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between NVO and AAPL?
NVO (Novo Nordisk A S) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: NVO or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.